Outlive: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
Line 16:
| pages = 496
| isbn = 978-0-593-23659-8
| goodreads_rating = 4.33
| goodreads_rating_date = 19 October 2025
| website = [https://peterattiamd.com/outlive/ peterattiamd.com]
}}
Line 36:
=== II ===
🧓 '''4 – Centenarians: the older you get, the healthier you have been.''' In Boston, the New England Centenarian Study has followed people 100 and older since 1995 at Boston University’s Chobanian & Avedisian School of Medicine, co-directed by Tom Perls, MD, MPH, and Stacy Andersen, PhD. Their registry includes roughly 2,500 centenarians, with about 600 aged 105–109 and 200 who are 110+, offering a rare window into extreme aging. U.S. census-linked estimates counted 89,739 centenarians in 2021, a tiny slice of the population but a fast-growing one. The data show a pattern often called “compression of morbidity,” a term James F. Fries introduced in a 1980 New England Journal of Medicine paper: disability and disease crowd into a shorter period at the end of life. Many centenarians delay the usual killers—atherosclerosis, cancer, dementia—until very late, then decline quickly. That profile is not magic; it is risk deferred across decades. Their histories read like a checklist of small edges: physical activity that never stopped, social ties that stayed tight, smoking rates that were low, and an uncanny knack for surviving infections and accidents. Genetics matter more as age climbs, but environment carries people most of the way to 80 and 90 before inheritance shows its hand. The lesson is not to copy the outliers but to reverse-engineer the path they took: fewer hits from the big diseases for as long as possible. Core idea: survivorship is path-dependent—if you’ve made it to extreme age, you have accumulated fewer damaging exposures and more protective ones. Mechanism: shift the probability curve early and keep shifting it so that the chronic-disease clock runs slower for longer.
🍽️ '''5 – Eat less, live longer: the science of hunger and health.''' The CALERIE trial—the first two-year randomized test of calorie restriction in healthy, non‑obese adults aged 21–51—assigned 218 people to target a 25% deficit versus ad libitum eating across multiple U.S. centers. Participants achieved about 12% sustained restriction, lost ~7–10 kg with ~70% from fat mass, and improved LDL‑C, blood pressure, insulin sensitivity, and inflammatory markers such as C‑reactive protein—benefits funded and tracked under the NIH. Animal data run deeper: a 2009 University of Wisconsin–Madison rhesus monkey study linked 30% restriction to better survival and fewer cancers, while a 2012 National Institute on Aging cohort initially saw no survival gain; a 2017 harmonized analysis resolved much of the conflict by showing that diet composition, feeding schedules, and starting age shaped outcomes. Across these lines, the consistent signal is metabolic: lower insulin and leptin, improved lipids, cooler inflammation, and preserved function. The crucial boundary is malnutrition—enough protein, micronutrients, and energy to train, sleep, and think—so the lever is “moderate, adequate, and sustained,” not starvation. Practically, this means planning for plateaus, tracking with objective markers, and cycling tactics so adherence holds for years, not weeks. Core idea: a persistent energy gap—managed, measured, and nutritionally adequate—retools the hormonal and inflammatory environment that drives chronic disease. Mechanism: reduce average exposure to anabolic and inflammatory signals (insulin, IGF‑1, chronic cytokines) while maintaining muscle, so risk curves bend before symptoms ever appear.
🛒 '''6 – The crisis of abundance: can our ancient genes cope with our modern diet?''' In 2019, an inpatient crossover study at the NIH Clinical Center fed 20 adults ultra‑processed and unprocessed diets for 14 days each, matched for presented calories, macronutrients, sugar, sodium, and fiber; participants ate ad libitum. On the ultra‑processed phase they consumed about 500 extra calories per day and gained weight; on the unprocessed phase they spontaneously ate less and lost weight—same nutrients on paper, different behavior in practice. The NOVA system from the University of São Paulo (introduced in 2009) helps name what changed: industrial formulations using fractionated ingredients, cosmetic additives, and techniques like extrusion that push palatability, convenience, and shelf life. In a food environment of endless variety, rapid eating rates, soft textures, and liquid calories, ancient appetite controls misfire. Energy density, speed, and reward stack the deck; some research suggests a “protein leverage” effect where diluted protein prompts higher total intake to hit a protein target. Add 24/7 access and aggressive marketing and you have a default that overwhelms willpower. The fix is architectural: engineer friction back into the system—shop the perimeter, pre‑portion protein and fiber‑rich foods, batch‑cook, and make the most tempting items less visible and less available. Core idea: the environment is the algorithm—change the inputs and the outputs change automatically. Mechanism: reshape cues (availability, energy density, eating rate) so satiety and appetite work for you rather than against you.
❤️ '''7 – The ticker: confronting and preventing heart disease, the deadliest killer on the planet.'''
| |||